Related Experiment Videos
Changes in sensitivity to anticancer drugs during TPA-induced cellular differentiation in a human T-lymphoblastoid
T Takimoto1, M Kubota, S Tsuruta
1Department of Pediatrics, Kyoto University, Japan.
Abstract:
After four days of treatment with 10(-8) M TPA, differentiation of the human T-lymphoblastoid cell line MOLT-4 was induced along the T cell lineage, confirmed by a fall in adenosine deaminase and 5'-ectonucleotidase and a rise in purine nucleoside phosphorylase activity. TPA-treated cells became resistant to the cytotoxic effects of 1-beta-D-arabinofuranosylcytosine (Ara-C), 9-beta-D-arabinofuranosyladenine (Ara-A), and 2-chlorodeoxyadenosine. This was, in part, due to the altered cell cycle distribution (accumulation of cells in the G1 phase), since the toxicity of Ara-C and Ara-A is S phase specific. The diminished rate of Ara-C transport concomitant with Ara-CTP formation after TPA treatment is considered to be the biochemical basis for this acquired resistance.
Insights
Treatment with 10(-8) M TPA induces T cell differentiation in MOLT-4 cells. TPA-treated cells exhibit resistance to cytotoxic drugs like Ara-C and Ara-A due to cell cycle changes and altered drug metabolism.
Area of Science:
- Immunology
- Cell Biology
- Pharmacology
Background:
- The human T-lymphoblastoid cell line MOLT-4 is a model for T cell differentiation studies.
- Cytotoxic chemotherapy agents like Ara-C and Ara-A are used in treating certain leukemias.
- Understanding drug resistance mechanisms is crucial for improving cancer therapy.
Purpose of the Study:
- To investigate the effects of 10(-8) M TPA on MOLT-4 cell differentiation.
- To determine if TPA treatment confers resistance to specific cytotoxic drugs.
- To elucidate the underlying mechanisms of acquired drug resistance.
Main Methods:
- Culturing and treating MOLT-4 cells with 10(-8) M TPA for four days.
- Assessing T cell lineage differentiation by measuring enzyme activities (adenosine deaminase, 5'-ectonucleotidase, purine nucleoside phosphorylase).
- Evaluating cellular resistance to cytotoxic agents (Ara-C, Ara-A, 2-chlorodeoxyadenosine) and analyzing cell cycle distribution.
- Measuring drug transport and intracellular metabolite formation (Ara-CTP).
Main Results:
- TPA treatment induced differentiation of MOLT-4 cells along the T cell lineage, evidenced by altered enzyme activities.
- TPA-treated cells demonstrated resistance to Ara-C, Ara-A, and 2-chlorodeoxyadenosine.
- Acquired resistance was partly attributed to cell cycle redistribution, with an accumulation of cells in the G1 phase.
- Diminished transport of Ara-C and reduced formation of Ara-CTP were observed in TPA-treated cells.
Conclusions:
- TPA effectively induces T cell differentiation in MOLT-4 cells.
- TPA treatment confers resistance to nucleoside analog chemotherapy drugs.
- Altered cell cycle and drug metabolism are key mechanisms underlying TPA-induced chemoresistance.